| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $81,648,158 | 17 | 100 |
| Hussain Abbas | director | 0 | $0 | 2 | $278,862 | $-278,862 |
| AFEYAN NOUBAR | director | 0 | $0 | 2 | $1.14M | $-1.14M |
| Klinger Shannon Thyme | Chief Legal Officer | 0 | $0 | 3 | $1.39M | $-1.39M |
| Mock James M | Chief Financial Officer | 0 | $0 | 1 | $4.69M | $-4.69M |
| Bancel Stephane | Chief Executive Officer | 0 | $0 | 1 | $28.72M | $-28.72M |
| Hoge Stephen | President | 0 | $0 | 8 | $45.45M | $-45.45M |
Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States, Europe, and other global markets. The company's diverse product pipeline encompasses various vaccine candidates: those for …
Over the last 12 months, insiders at Moderna, Inc. have bought $0 and sold $81.65M worth of Moderna, Inc. stock.
On average, over the past 5 years, insiders at Moderna, Inc. have bought $6.01M and sold $256.64M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 31,620 shares for transaction amount of $1M was made by SAGAN PAUL (director) on 2025‑03‑03.
| 2026-10-15 | Sale | Hoge Stephen | President | 39,145 0.0092% | $220.72 | $8.64M | -6.63% | |
| 2026-10-14 | Sale | Hoge Stephen | President | 39,224 0.0093% | $213.48 | $8.37M | -2.22% | |
| 2026-09-15 | Sale | Hoge Stephen | President | 40,281 0.0103% | $146.07 | $5.88M | +40.94% | |
| 2026-09-14 | Sale | Hoge Stephen | President | 40,294 0.01% | $144.13 | $5.81M | +37.27% | |
| 2026-09-10 | Sale | Mock James M | Chief Financial Officer | 34,836 0.0087% | $134.49 | $4.69M | +46.02% | |
| 2026-09-01 | Sale | Klinger Shannon Thyme | Chief Legal Officer | 3,471 0.0008% | $139.95 | $485,766 | +27.79% | |
| 2026-08-05 | Sale | Bancel Stephane | Chief Executive Officer | 499,246 0.1286% | $57.52 | $28.72M | +209.95% | |
| 2026-07-15 | Sale | Hoge Stephen | President | 53,336 0.0133% | $67.60 | $3.61M | +118.61% | |
| 2026-06-15 | Sale | Hoge Stephen | President | 53,336 0.0132% | $51.37 | $2.74M | +167.81% | |
| 2026-06-04 | Sale | Klinger Shannon Thyme | Chief Legal Officer | 3,471 0.0008% | $50.00 | $173,550 | +162.86% | |
| 2026-05-21 | Sale | AFEYAN NOUBAR | director | 9,263 0.0023% | $46.84 | $433,879 | +65.38% | |
| 2026-05-15 | Sale | Hoge Stephen | President | 53,336 0.0133% | $48.40 | $2.58M | +49.16% | |
| 2026-05-01 | Sale | Hussain Abbas | director | 5,682 0.0015% | $46.63 | $264,952 | +49.56% | |
| 2026-03-02 | Sale | Klinger Shannon Thyme | Chief Legal Officer | 13,885 0.0035% | $52.29 | $726,047 | +9.88% | |
| 2026-02-23 | Sale | Hoge Stephen | President | 160,009 0.0398% | $48.84 | $7.81M | +14.16% | |
| 2025-12-11 | Sale | AFEYAN NOUBAR | director | 23,853 0.0061% | $29.48 | $703,306 | +80.80% | |
| 2025-12-09 | Sale | Hussain Abbas | director | 504 0.0001% | $27.60 | $13,910 | +89.64% | |
| 2025-06-11 | Sale | Hussain Abbas | director | 312 <0.0001% | $28.00 | $8,736 | +15.93% | |
| 2025-03-03 | Bancel Stephane | Chief Executive Officer | 160,314 0.0429% | $31.22 | $5M | -9.05% | ||
| 2025-03-03 | SAGAN PAUL | director | 31,620 0.0086% | $31.76 | $1M | -9.05% |
| Bancel Stephane | Chief Executive Officer | 6187791 1.5499% | $1.41B | 1 | 417 | <0.0001% |
| Trieu Vuong | Chairman of the Board | 11117141 2.7846% | $2.54B | 2 | 0 | |
| Ramelli Joseph W. | Chief Executive Officer | 440653 0.1104% | $100.66M | 4 | 0 | |
| SAGAN PAUL | director | 312027 0.0782% | $71.28M | 2 | 1 | +126.55% |
| FRENCH J MICHAEL | CEO | 10000 0.0025% | $2.28M | 1 | 0 |
$961,890,236 | 276 | 22.46% | $23.97B | |
$2,765,836 | 72 | 20.00% | $10.77B | |
$108,876,545 | 67 | 72.81% | $14.6B | |
$2,449,191,716 | 58 | 16.50% | $100.2B | |
$11,991,408 | 51 | 18.36% | $22.91B |
| Increased Positions | 288 | +35.25% | 51M | +18.26% |
| Decreased Positions | 337 | -41.25% | 25M | -9.14% |
| New Positions | 114 | New | 21M | New |
| Sold Out Positions | 77 | Sold Out | 4M | Sold Out |
| Total Postitions | 768 | -6% | 304M | +9.11% |
| Vanguard Group Inc | $1.27M | 10.53% | 41.19M | -523,410 | -1.25% | 2025-09-30 |
| Blackrock, Inc. | $911,232.00 | 7.55% | 29.53M | +916,447 | +3.2% | 2025-09-30 |
| Baillie Gifford & Co | $674,188.00 | 5.59% | 21.85M | -247,458 | -1.12% | 2025-09-30 |
| State Street Corp | $527,971.00 | 4.38% | 17.11M | -162,036 | -0.94% | 2025-09-30 |
| Fmr Llc | $379,711.00 | 3.15% | 12.3M | -7M | -37.37% | 2025-09-30 |
| Morgan Stanley | $307,434.00 | 2.55% | 9.96M | +2M | +22.94% | 2025-09-30 |
| Geode Capital Management, Llc | $285,435.00 | 2.37% | 9.25M | +372,072 | +4.19% | 2025-09-30 |
| Invesco Ltd. | $253,551.00 | 2.1% | 8.22M | +1M | +15.7% | 2025-09-30 |
| Theleme Partners Llp | $249,003.00 | 2.06% | 8.07M | +200,000 | +2.54% | 2025-09-30 |
| Two Sigma Investments, Lp | $232,375.00 | 1.93% | 7.53M | +570,773 | +8.2% | 2025-09-30 |